Читать книгу Cases in Medical Microbiology and Infectious Diseases - Melissa B. Miller - Страница 62

1. Bartlett JG. 2011. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 52(Suppl 4):S296–S304.

2. File TM Jr. 2010. Case studies of lower respiratory tract infections: community-acquired pneumonia. Am J Med 123(4 Suppl):S4–S15.

3. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. 2013. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 369:155–163.

4. Jedrzejas MJ. 2001. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65:187–207.

5. Musher DM. 2012. Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults? Clin Infect Dis 55:265–267.

6. Musher DM, Montoya R, Wanahita A. 2004. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 39:165–169.

7. Richter SS, Heilmann KP, Coffman SL, Huynh HK, Brueggemann AB, Pfaller MA, Doern GV. 2002. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994–2000. Clin Infect Dis 34:330–339.

8. Rueda AM, Serpa JA, Matloobi M, Mushtaq M, Musher DM. 2010. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore) 89:331–336.

9. Werno AM, Murdoch DR. 2008. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis 46:926–932.

10. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343:1917–1924.